Written by Mehr Gill |New Delhi |Updated: August 27, 2019 6:59:51 am
Telling Numbers: Cardiovascular disease burden in India, and state highs & lows
Three-quarters of CVD-related deaths happen in lower-middle income countries, according to the World Health Organization, which classifies India among such countries.
Last week, The Lancet published the results of a clinical trial with PolyPill tablets (a combination of aspirin and atorvastatin) conducted on older patients of cardiovascular disease (CVD) in Iranian adults. It concluded that a fixed dose of the tablets along with therapy may help reduce the CVD burden, particularly in low and middle income countries.
No hay comentarios:
Publicar un comentario